Figures & data
Table 1 Annual absolute number of hip fractures, age- and sex-specific and standardized incidence rates of hip fractures in subjects 60 years of age and older
Figure 1 Age-adjusted and standardized to 2006 Australian population rates of hip fracture in women and men aged ≥60 years and prescriptions of bisphosphonates, strontium ranelate, and hormone replacement therapy in the Australian Capital Territory from 1999 to 2008.
Table 2 Linear regression analysis between the number of bisphosphonate prescriptions (×103) and age-standardized hip fracture rates (per 100,000 person-years) in the elderly in 1999–2008 in the Australian Capital Territory
Figure 2 The relationship between the total annual number of prescriptions (×103) for bisphosphonates and age-standardized hip fracture rates (per 100,000 personyears) in A) females, B) males, and C) the total elderly population in the Australian Capital Territory (1999–2008). Regression lines with 95% confidence intervals.
